Description
AOD-9604 Technical Overview
AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone. Its sequence corresponds to residues 177–191 of human growth hormone with an additional N-terminal tyrosine residue.
The resulting 16-residue peptide was developed for experimental research into metabolic signaling and the biological activity of selected growth hormone fragments.
Published experimental and clinical investigations have examined AOD-9604 in relation to adipose tissue biology, lipid-associated metabolic pathways, and body-weight-related outcomes.
Available clinical studies have not established AOD-9604 as an effective treatment for obesity or other medical conditions.
Compound Specifications
| Property | Value |
|---|---|
| Compound Name | AOD-9604 |
| Classification | Modified growth hormone fragment |
| Structural Origin | Human GH residues 177–191 with an additional N-terminal residue |
| Sequence Length | 16 amino acid residues |
| Related Parent Hormone | Human Growth Hormone |
| Research Category | Metabolic Research |
| Vial Content | 5mg |
Storage and Handling
- Follow manufacturer-recommended stability conditions.
- Protect from moisture and contamination.
- Use appropriate peptide handling procedures.
Lyophilized Format
AOD-9604 may be supplied as a lyophilized peptide. Actual physical form and stability depend on the manufacturer’s formulation.
Research Use Disclaimer
AOD-9604 is not FDA-approved for human therapeutic use. It is not intended for human or veterinary administration, weight management, or clinical applications.
Frequently Asked Questions
What Is AOD-9604?
A synthetic peptide derived from the C-terminal region of human growth hormone.
How Many Amino Acids Does AOD-9604 Contain?
Sixteen residues.
Is AOD-9604 the Same as Full-Length HGH?
No. AOD-9604 is a short peptide derived from the growth hormone sequence.
What Research Areas Involve AOD-9604?
Growth hormone fragment biology, adipose tissue research, and experimental lipid metabolism.
Is AOD-9604 an FDA-Approved Weight-Loss Medicine?
No.
Research Overview
AOD-9604 was developed to investigate metabolic activity associated with selected growth hormone-derived peptide sequences.
Growth Hormone Fragment Research
Experimental studies have compared short growth hormone-derived sequences with properties of the parent hormone.
Adipose Tissue Research
Laboratory investigations have examined AOD-9604-associated responses in experimental adipose tissue models.
Lipid Metabolism Research
Research has explored potential relationships between the peptide and lipid-associated metabolic pathways.
Clinical Research
Clinical development included studies evaluating body-weight-related outcomes, but available evidence has not established efficacy for obesity treatment.
Research Applications
| Research Area | In Vitro Application |
|---|---|
| Peptide Chemistry | Growth hormone fragment characterization |
| Adipocyte Research | Experimental cellular response assays |
| Metabolic Research | Lipid pathway analysis |
References
Certificate of Analysis (COA)
Documentation should establish the complete peptide sequence, chemical identity, purity, and actual content.
Reviews
There are no reviews yet.